Anthony B. Evnin, Ph.D. served as a Partner at Venrock, a venture capital firm, from 1975 through 2021. Dr. Evnin currently serves on the Board of Directors of AVEO Pharmaceuticals and Infinity Pharmaceuticals as well as on the Boards of two private companies, Constellation Pharmaceuticals and Juno Therapeutics. He is a Trustee of The Rockefeller University, a Member of the Board of Overseers and Managers of Memorial Sloan-Kettering Cancer Center, a Trustee of The Jackson Laboratory, a Director of the New York Genome Center, a Member of the Board of Directors of the Albert and Mary Lasker Foundation, and a Trustee Emeritus of Princeton University. Dr. Evnin received an A.B. in chemistry from Princeton University and a Ph.D. in chemistry from the Massachusetts Institute of Technology. Dr. Evnin has served as a director of AVEO since 2002 and is the chairperson of the nominating and governance committee and a member of the audit committee.
